After-hours movers: Apple, Amazon, and Google all fall as results disappoint
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/7/2026
- Wall Street ends lower as solid jobs data fuels hawkish Fed bets
- US nonfarm payrolls blow past expectations in August; unemployment rate steady at 4.1%
- BofA's Hartnett says stay long commodities and gold as 'policy panic' works
- Oil ends week higher on renewed US-Iran strikes, diesel hits record
- TikTok owner ByteDance said to secure $29.6bn loan for AI push
- S&P Dow Jones Indices adds Bloom Energy to S&P 500 index
- Citi highlights best Gen AI stocks to own for 2027
- Dell’s earning report was bullish for Intel CPU demand, analyst says
- Wall Street ends lower as solid jobs data fuels hawkish Fed bets
- Netflix raises prices in Germany and Austria, Citi comments
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Google releases new AI 'Bard' to testers ahead of public release
February 6, 2023 2:49 PM ESTGoogles parent company, Alphabet Inc, (NASDAQ: GOOG) announced in a blog post on Monday that the company is planning to launch a chatbot service called Bard. Bard is powered by LaMDA, Google's AI that can generate human-like prose. The technology company opened the conversational AI service to test users for feedback, and will be followed by a public release in the coming... More
Evercore ISI Removes Apple (AAPL) From Tactical Outperform List
February 3, 2023 11:30 AM ESTEvercore ISI analyst Amit Daryanani reiterated an Outperform rating and $190.00 price target on Apple (NASDAQ: AAPL)
The analyst comments "We are removing AAPL from the Tactical Outperform list as the potential catalyst for our call took place yesterday during their earnings print. AAPL reported Dec-qtr results of $117B/1.88 vs. street at $124B/1.95 with sales declining 5% y/y due to headwinds from f/x (~800bps), production... More
Gilead Sciences shares gain after topping expectations despite lower remdesivir sales
February 3, 2023 9:46 AM ESTGilead Sciences (NASDAQ: GILD) shares rallied in early Friday trading in reaction to the company's latest earnings report, which saw it beat top and bottom-line consensus expectations.
The biopharmaceutical company posted fourth-quarter earnings of $1.67 per share, $0.17 above the analyst consensus estimate of $1.50, while revenue for the quarter came in at $7.4 billion, beating expectations of $6.66 billion.
The company's revenue increased year-over-year, primarily due to increased sales in Oncology, HIV, and hepatitis C virus. However, this was partially offset by... More
Deutsche Bank Downgrades Ford (F) to Sell 'on operational shortfalls and earnings risk'
February 3, 2023 6:08 AM ESTDeutsche Bank analyst Emmanuel Rosner downgraded Ford (NYSE: F) from Hold to Sell with a price target of $11.00 (from $13.00).
The analyst comments "We are downgrading our Ford rating to Sell, following its large 4Q22 miss and new aggressive 2023 guidance, which in our view showcase considerable... More
